-
How will pharmacovigilance look in 2030?
How will pharmacovigilance look in 2030?
-
How will pharmacovigilance look in 2030?
How will pharmacovigilance look in 2030?
Smarter collection and reporting of safety reports of suspected adverse reactions, measurement of on-market performance of medicines, and improved engagement between regulators, patients and healthcare professionals will be key elements of pharmacovigilance in 2030.
-
New EMA infographic describes journey of a medicine
New EMA infographic describes journey of a medicine
-
New EMA infographic describes journey of a medicine
New EMA infographic describes journey of a medicine
Take a look at EMA’s interactive timeline which illustrates the journey of a medicine for human use authorised through EMA, from initial research to discussions on patient access to medicines across the EU. This initiative aims to improve understanding of how EMA works.
-
Responsible use of antibiotics: what’s your role?
Responsible use of antibiotics: what’s your role?
-
Responsible use of antibiotics: what’s your role?
Responsible use of antibiotics: what’s your role?
Antimicrobial resistance is a major public health threat, which we all need to tackle collectively. To mark European Antibiotic Awareness Day 2019, EMA has launched a social media campaign to highlight the importance of using antibiotics responsibly.
-
Updated guidance for industry on preparing for Brexit
Updated guidance for industry on preparing for Brexit
-
Updated guidance for industry on preparing for Brexit
Updated guidance for industry on preparing for Brexit
EMA and the European Commission provide additional information on exemptions for batch testing to help pharmaceutical companies prepare for the UK’s withdrawal from the EU.
